A federal judge has rejected OxyContin maker Purdue Pharma’s sweeping deal to settle thousands of lawsuits over the toll of opioids.
DEA administrator Anne Milgram discusses the record overdose deaths in the U.S. and dangers of synthetic opioids.NEW YORK -- A federal judge rejected OxyContin maker Purdue Pharma’s bankruptcy settlement of thousands of lawsuits over the opioid epidemic Thursday because of a provision that would protect members of the Sackler family from facing litigation of their own.
"It will delay, and perhaps end, the ability of creditors, communities, and individuals to receive billions in value to abate the opioid crisis,” said Steve Miller, chairman of the Purdue board of directors. “These funds are needed now more than ever as overdose rates hit record-highs, and we are confident that we can successfully appeal this decision and deliver desperately needed funds to the communities and individuals suffering in the midst of this crisis.
Purdue sought bankruptcy protection in 2019 as it faced thousands of lawsuits claiming the company pushed doctors to prescribe OxyContin, helping spark an opioid crisis that has been linked to more than 500,000 deaths in the U.S. over the last two decades. In return, members of the wealthy family would get protection from lawsuits over their role in the opioid crisis — both the 860 already filed and any others in the future.
A bankruptcy court judge approved the plan over the objections in September. But the opponents appealed to McMahon's court.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Judge rejects Purdue Pharma’s opioid settlement over protections for Sackler familyA judge has rejected OxyContin maker Purdue Pharma’s bankruptcy settlement of thousands of lawsuits over the opioid epidemic because of a provision that would protect members of the Sackler family from facing litigation of their own.
Les mer »
Judge Throws Out Purdue Pharma’s Deal to Shield Sacklers From Opioid LawsuitsA federal judge overturned a roughly $4.5 billion settlement between OxyContin maker Purdue and members of the Sackler family who own the drugmaker, a surprising decision that raises questions about the future of the company and its owners
Les mer »
Judge rejects Purdue Pharma’s sweeping opioid settlement | AP NewsNEW YORK (AP) — A judge has rejected OxyContin maker Purdue Pharma’s bankruptcy settlement of thousands of lawsuits over the opioid epidemic because of a provision that would protect members of the Sackler family from facing litigation of their own.
Les mer »
Judge rejects Purdue Pharma’s sweeping opioid settlement | AP NewsNEW YORK (AP) — A judge has rejected OxyContin maker Purdue Pharma’s bankruptcy settlement of thousands of lawsuits over the opioid epidemic because of a provision that would protect members of the Sackler family from facing litigation of their own.
Les mer »
Judge rejects Purdue Pharma’s opioid settlement over protections for Sackler familyA judge has rejected OxyContin maker Purdue Pharma’s bankruptcy settlement of thousands of lawsuits over the opioid epidemic because of a provision that would protect members of the Sackler family from facing litigation of their own.
Les mer »